Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VCD vs CTD in Newly Diagnosed Multiple Myeloma
NCT03402295Phase 3Completed
- Sponsor
- Grupo de Estudos Multicêntricos em Onco-Hematologia
- Start
- Jun 2009
- Primary completion
- Jun 2014
- Modality
- Small Molecules, Modified Peptides
01
Overview
A Phase 3 trial of bortezomib in multiple myeloma (MM), sponsored by Grupo de Estudos Multicêntricos em Onco-Hematologia. Started Jun 2009; status: completed.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT03402295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03402295.